Methoxymethane

Methoxymethane

SCHEMBL6774591

CCCCOCCCC.COC.Nc1nc(N)nc(N)n1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
HRH2 P25021 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
CDK1 P06493 3/20 0.41
CCNB1 P14635 3/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CCNA1 P78396 2/20 0.41
PIN1 Q13526 1/20 0.41
HTT P42858 2/20 0.40
NOS1 P29475 1/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP3A4 P08684 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
TLR8 Q9NR97 3/20 0.37
TLR7 Q9NYK1 3/20 0.37
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9769720 0.95 TSHR (0.48) TSHRHRH2HRH3CDK1CCNB1
Formaldehyde SCHEMBL27746386 0.89 TSHR (0.43) TSHRHRH2HRH3CDK1CCNB1
Butoxyethanol SCHEMBL9322659 0.85 TSHR (0.68) TSHRCDK1CCNB1CCNA2CDK2
SCHEMBL27642129 0.85 TSHR (0.56) TSHRCDK1CCNB1CCNA2CDK2
SCHEMBL8214121 0.84 TLR8 (0.42) HRH2HRH3CDK1CCNB1CCNA2
SCHEMBL4363406 0.83 TSHR (0.46) TSHRHRH2HRH3CDK1CCNB1
Methoxymethane SCHEMBL6557527 0.80 TSHR (0.63) TSHRHTTLMNACYP3A4ADRB2
SCHEMBL15438152 0.78 TLR8 (0.42) HTTLMNATLR8TLR7MEN1
Hexane SCHEMBL28379586 0.77 CASP1 (0.48) TSHRCDK1CCNB1CCNA2CDK2
SCHEMBL11309403 0.77 MEN1 (0.71) TSHRCDK1CCNB1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6818726-B2 FOR INTERMEDIATES AND MOLDED MATERIALS WITH IMPROVED TOUGHNESS AND HIGH FLAME RESISTANCE AND STRENGTH AGROLINZ MELAMIN GMBH (AT) 2004-11-16 US disclosed
US-6818768-B2 20-70% BY WEIGHT TRIAZINE DERIVATIVES WITH HYDROXYALKYL AMINO GROUPS AND 30-80% OF TRIAZINE DERIVATIVES WITH BIS/HYDROXYLAKYL)IMINO GROUP AGROLINZ MELAMIN GMBH (AT) 2004-11-16 US disclosed
US-20030050474-A1 Mixtures of triazine derivatives free from polyalkylene oxide AGROLINZ MELAMIN GMBH (AT) 2003-03-13 US disclosed
US-20030045667-A1 Polymers made from triazine derivatives AGROLINZ MELAMIN GMBH (AT) 2003-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030050474-A1 Mixtures of triazine derivatives free from polyalkylene oxide TAAR5, TAAR1, ARNT TSHR 375/4885HRH2 79/4885HRH3 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.